Literature DB >> 12526694

Non-natural cell surface receptors: synthetic peptides capped with N-cholesterylglycine efficiently deliver proteins into Mammalian cells.

Scott E Martin1, Blake R Peterson.   

Abstract

Protein toxins such as shiga toxin and cholera toxin penetrate into cells by binding small molecule-based cell surface receptors localized to cholesterol and sphingolipid-rich lipid raft subdomains of cellular plasma membranes. Molecular recognition between these toxins and their receptors triggers endocytic protein uptake through endogenous membrane trafficking pathways. We report herein the synthesis of functionally related non-natural cell surface receptors comprising peptides capped with N-cholesterylglycine as the plasma membrane anchor. The peptide moieties of these receptors were based on high-affinity epitopes of anti-hemaglutinin antibodies (anti-HA), anti-Flag antibodies, and a moderate-affinity Strep Tag II peptide ligand of the streptavidin protein from Streptomyces avidini. These non-natural receptors were directly loaded into plasma membranes of Jurkat lymphocytes to display peptides from lipid rafts on the cell surface. Molecular recognition between these receptors and added cognate anti-HA, anti-Flag, or streptavidin proteins resulted in rapid clathrin-mediated endocytosis; fluorescent target proteins were completely internalized within 4-12 h of protein addition. Analysis of protein uptake by epifluorescence microscopy and flow cytometry revealed intracellular fluorescence enhancements of 100-fold to 200-fold (10 microM non-natural receptor) with typically >99% efficiency. This method enabled intracellular delivery of a functional Escherichia coli beta-galactosidase enzyme conjugated to Protein A from Staphylococcus aureus. We termed this novel delivery strategy "synthetic receptor targeting", which is an efficient method to enhance macromolecular uptake by decorating mammalian cells with chemically defined synthetic receptors that access the molecular machinery controlling the organization of cellular plasma membranes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12526694     DOI: 10.1021/bc025601p

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  7 in total

Review 1.  Synthetic cell surface receptors for delivery of therapeutics and probes.

Authors:  David Hymel; Blake R Peterson
Journal:  Adv Drug Deliv Rev       Date:  2012-02-25       Impact factor: 15.470

2.  Multifunctional prenylated peptides for live cell analysis.

Authors:  James W Wollack; Nicholette A Zeliadt; Daniel G Mullen; Gregg Amundson; Suzanne Geier; Stacy Falkum; Elizabeth V Wattenberg; George Barany; Mark D Distefano
Journal:  J Am Chem Soc       Date:  2009-06-03       Impact factor: 15.419

Review 3.  The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis.

Authors:  Akshay Jain; Kun Cheng
Journal:  J Control Release       Date:  2016-11-16       Impact factor: 9.776

4.  Lipid modification of proteins through sortase-catalyzed transpeptidation.

Authors:  John M Antos; Gwenn M Miller; Gijsbert M Grotenbreg; Hidde L Ploegh
Journal:  J Am Chem Soc       Date:  2008-12-03       Impact factor: 15.419

Review 5.  Metabolic glycoengineering: sialic acid and beyond.

Authors:  Jian Du; M Adam Meledeo; Zhiyun Wang; Hargun S Khanna; Venkata D P Paruchuri; Kevin J Yarema
Journal:  Glycobiology       Date:  2009-08-12       Impact factor: 4.313

6.  Surface engineering of macrophages with nanoparticles to generate a cell-nanoparticle hybrid vehicle for hypoxia-targeted drug delivery.

Authors:  Christopher A Holden; Quan Yuan; W Andrew Yeudall; Deborah A Lebman; Hu Yang
Journal:  Int J Nanomedicine       Date:  2010-02-02

7.  Remote control of tissue interactions via engineered photo-switchable cell surfaces.

Authors:  Wei Luo; Abigail Pulsipher; Debjit Dutta; Brian M Lamb; Muhammad N Yousaf
Journal:  Sci Rep       Date:  2014-09-10       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.